Panacos Pharmaceuticals Inc. Announces Stock Listing Transfer to The Nasdaq Capital Market
Published: Jul 30, 2008
WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (NASDAQ: PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced it has received approval from the Nasdaq Listing Qualifications Department to transfer the listing of its common stock from The Nasdaq Global Market to The Nasdaq Capital Market. The transfer became effective as of the opening of the market on July 29, 2008.